Skip to search formSkip to main contentSkip to account menu

bucillamine

Known as: tiobutarit, N-(2-mercapto-2-methylpropionyl)-L-cysteine, 2-mercapto-2-methylpropanoyl-L-cysteine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Anti-Inflammatory Agents, Non-SteroidalAntioxidantsCysteine

Narrower (1)

SA 96
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study
Disease-modifying antirheumatic drug (DMARD) combination therapies are used widely, but there have been few reports clearly… 
2000
2000
Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
OBJECTIVE To investigate the novel antiinflammatory mechanism of a disease-modifying antirheumatic drug, bucillamine, on… 
1997
1997
A comparison between bucillamine and d-penicillamine in the treatment of rheumatoid arthritis
Abstract In order to compare the clinical effect and the frequency of side effects of d-penicillamine and bucillamine, we… 
1996
1996
Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
OBJECTIVE The mechanism of disease modifying antirheumatic drugs (DMARD) is incompletely understood. We investigated in vitro the… 
1996
1996
Covalent Binding Between Bucillamine Derivatives and Human Serum Albumin
AbstractPurpose. To clarify the mechanism of covalent binding between human serum albumin (HSA) and drugs containing thiol groups… 
1995
1995
YELLOW NAIL INDUCED BY BUCILLAMINE
A 67-year-old man with a 4-year history of rheumatoid arthritis (RA) presented at the Dermatology Department of Tokyo… 
1994
1994
Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells.
OBJECTIVE Clinical trials have suggested that the efficacy of bucillamine (BUC) in rheumatoid arthritis (RA) may be superior to… 
1993
1993
Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites.
OBJECTIVE Bucillamine: N-(2-mercapto-2-methyl-propanoyl)-L-cysteine has recently been suggested to be effective in the treatment… 
1991
1991
Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
This paper describes pathological and clinical investigations of glomerular lesions in bucillamine-induced nephropathy by… 
1987
1987
Serum oxidation activities and rheumatoid arthritis.
The serum oxidation activity (SOA) of patients with rheumatoid arthritis (RA) and other connective-tissue diseases (OCTD) was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)